Quantum Surgical Archives - Medical Design Sourcing

Quantum Surgical makes its first surgical robot sale in the U.S.

The Epione surgical robot system. [Image from Quantum Surgical]Quantum Surgical announced that it made the first sale of its Epione surgical robot platform in the U.S.

Popular Equipment Finance (DBA K2 Capital Group), a leader in equipment financing solutions, acquired the Epione robot. The company works with healthcare organizations across the U.S., including a cancer center that used Epione in May 2023. That cancer center now entered into a lease with K2 for the Epione system, the company announced last week.

Montpellier, France-based Quantum Surgical’s Epione, a robotic-assisted percutaneous ablation system, uses a robotic arm, a navigation system and a camera. It inserts a needle through the skin to the tumor and destroys it. Epione robot enables the early and minimally invasive treatment of abdominal tumors. It allows surgeons to treat inoperable tumors, including ones particularly hard to reach due to size or location.

Epione can treat tumors in…

Quantum Surgical earns regulatory nod for surgical robot in China

The Epione surgical robot system. [Image from Quantum Surgical]Quantum Surgical announced today that the National Medical Products Administration (NMPA) authorized its Epione surgical robot in China.

News of the regulatory nod comes just weeks after the last one for Quantum. It announced CE mark expansion for Epione to treat lung tumors earlier this month.

Montpellier, France-based Quantum’s flagship Epione robot enables the early and minimally invasive treatment of abdominal tumors. It allows surgeons to treat inoperable tumors that are particularly hard to reach due to size or location. The simple, effective platform provides treatment at an early stage.

A robotic-assisted percutaneous ablation system, Epione uses a robotic arm, a navigation system and a camera. It inserts a needle through the skin to the tumor and destroys it.

Epione can treat tumors in the liver, kidney and pancreas, in addition to the lung expansion it just received. It…

Quantum Surgical wins CE mark to treat lung tumors with its surgical robot

The Epione surgical robot system. [Image from Quantum Surgical]Quantum Surgical recently announced that it received expanded CE mark approval for the use of its Epione surgical robotic platform.

The Montpellier, France-based company won expanded indications for Epione in the treatment of lung tumors.

Epione, the company’s flagship product, offers curative treatment for cancers. Quantum Surgical designed it to plan, target, deliver and confirm tumor ablation in a minimally invasive procedure. The percutaneous ablation system uses a robotic arm, a navigation system and a camera.

It enables physicians to treat inoperable, particularly difficult-to-reach tumors at an early stage in a simple and effective way. Epione’s uses include the treatment of abdominal tumors, including in the liver, kidney and pancreas.

Having received FDA 510(k) clearance in March 2022, Epione has treated more than 200 patients in France and the U.S. to date.

Qu…

And the best medical device innovation of 2022 goes to…

The Cala Health Cala Trio [Image courtesy of Cala Health]

The Galien Foundation last night honored Cala Health’s Cala Trio essential tremor treatment wearable as 2022’s best medical device innovation.

The foundation describes its Prix Galien awards as the global equivalent of the Nobel Prize for the life science industry.

The Cala Trio offers a non-invasive method to send signals to the brain to treat essential tremor rather than deep-brain stimulation. It was one of two dozen devices that were nominees in this year’s competition. (Here is Medical Design & Outsourcing‘s roundup of the full 24.)

More about Cala Health and its Cala Trio

MDO recently interviewed Cala Health co-founder and Chief Scientific Officer Kate Rosenbluth and CEO Renee Ryan about the creation of the technology. The Cala Trio has FDA clearance as an external upper limb tremor stimulator, available by…

8 more surgical robotics companies you need to know

The Versius surgical robotics system [Image from CMR Surgical] You know the big hitters in surgical robotics. Here are some of the companies you may not know about, but you should keep an eye on them.

Last month, MassDevice compiled a list of 16 surgical robotics companies you need to know. That list included the usual suspects, like Intuitive, Medtronic, Johnson & Johnson and more. But, a list of 16 companies hardly scratches the surface.

Competition continues to heat up what is already one of the hottest spaces in medtech. Here are eight more companies that made waves in robot-assisted surgery recently:

Company Robotic system CMR Surgical Versius Medical Microinstruments Symani Levita Magnetics MARS Virtuoso Surgical Virtuoso System eCential Robotics Surgivisio Globus Medical ExcelsiusGPS Distalmotion Dexter Quantum Surgical Epione CMR Surgical

Cambridge, United Kingdom-based CMR Surgical took a massive step forward in 2021.

The …

FDA clears Quantum Surgical’s robot-assisted tumor ablation tech

[Image from Quantum Surgical]

Quantum Surgical announced today that it received FDA 510(k) clearance for its Epione interventional oncology robotics platform.

Montpellier, France–based Quantum Surgical designed Epione, a robot-assisted system, to plan, target, deliver and confirm tumor ablation in minimally invasive liver cancer treatment.

Get the full story at our sister site, MassDevice.

FDA clears Quantum Surgical’s robot-assisted tumor ablation tech

[Image from Quantum Surgical]Quantum Surgical announced today that it received FDA 510(k) clearance for its Epione interventional oncology robotics platform.

Montpellier, France-based Quantum Surgical designed Epione, a robot-assisted system, to plan, target, deliver and confirm tumor ablation in minimally invasive liver cancer treatment.

According to a news release, Epione enables clinicians to perform safe and effective percutaneous tumor ablations, expanding the option of such treatment to more patients battling liver cancer. Clearance permits marketing for the Epione interventional oncology robot in the U.S., with Quantum Surgical planning to extend indications for the platform to other organs.

Quantum Surgical added that it also has intentions to develop artificial intelligence (AI)-based decision-support features for the Epione platform.

“This clearance enables interventional oncologists to access state-of-the-art technology that has the potent…